期刊文献+

凝血指标与肺癌患者病情相关性研究 被引量:3

Correlation Between Indexes of Blood Coagulation and Level of Severity in Lung Cancer
下载PDF
导出
摘要 目的探讨肺癌患者初发、缓解、复发时各凝血指标的相关性。方法对照组30名和经病理或细胞学证实的100例肺癌患者,根据临床病例分析分为初发组、复发组和缓解组。对各组凝血指标,包括凝血酶原时间(PT)、部分凝血活酶时间(APTT)、纤维蛋白原时间(FIB)、D-二聚体、抗凝血酶Ⅲ(AT-Ⅲ)进行测定,比较各组间有无差异,并分析它们与肺癌病情变化的关系。结果肺癌患者初发组和复发组血浆D-二聚体、FIB水平高于缓解组和对照组,AT-Ⅲ水平低于缓解组和对照组,差异有统计学意义(P<0.05)。PT、APTT差异无统计学意义(P>0.05)。肺癌患者D-二聚体、FIB水平高于对照组,AT-Ⅲ水平低于对照组,差异有统计学意义(P<0.05),肺癌Ⅰ~Ⅱ期与Ⅲ~Ⅳ期比较以上三指标差异有统计学意义(P<0.05)。结论常规凝血指标可以作为肺癌的诊断、治疗监测和预后指标,评估病情发展趋向。 Objective To explore the correlation between the blood coagulation and the level of severity patients with lung cancer.Methods 100 patients with lung cancer confirmed by pathological or cytology were divided into incipient group,recurrence group and remission group.The blood coagulation index including prothrombin time(PT),part blood coagulation time(APTT) live enzyme,fibrinogen time(FIB),d-dimer and anticoagulant enzyme Ⅲ(AT-Ⅲ) in patients and 30 health controls were detected.Results The plasma levels of d-dimer and FIB in incipient group and recurrence group patients were higher,and AT Ⅲ level were lower than that of remission group and controls(P0.05).There were no significant difference in PT and APTT between them(P0.05).The levels of d-dimer and FIB in patients with lung cancer were higher and AT-Ⅲ levels were lower than those of control group(P0.05).There were significant difference in levels of d-dimer,FIB and AT-Ⅲ levels between the patients with lung cancer in I-II stages and III-IV stages(P0.05).Conclusion The routine blood coagulation index could be used as an index in diagnosis,treatment and evaluation of prognosis of lung cancer.
出处 《标记免疫分析与临床》 CAS 2012年第5期261-263,共3页 Labeled Immunoassays and Clinical Medicine
关键词 肺癌 肿瘤 凝血指标 Lung cancer Tumors Blood coagulation
  • 相关文献

参考文献8

  • 1ZHENGShu CAIShanrong.Colorectal Cancer Epidemiology and Prevention Study in China(中国人大肠癌的流行病学研究)[J].The Chinese-German Journal of Clinical Oncology,2003,2(2):72-75. 被引量:45
  • 2Lee A Y. Thrombosis and cancer: the role of secreting for occultcan- cer and recognizing the underlying biological mechanisms[ J]. Hema- tology Am Soc Hematol Educ Program, 2006:438-443.
  • 3Righini M, Le Gal G, De Lucia S, et al. Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism. Thromb haemost, 2006,95(4): 715-719.
  • 4贾玉龙,程石,汪岩,李娜,宋茂民.下肢深静脉血栓形成时D-二聚体监测的临床意义[J].中国医刊,2007,42(3):36-38. 被引量:40
  • 5薛文成,万楠,罗军,陈渝宁,方秀菊,孟冬娅.检测血浆D-二聚体在下肢静脉血栓诊断中的应用[J].实用诊断与治疗杂志,2007,21(2):113-114. 被引量:19
  • 6Sutherland D E, Weitz I C, Liebman H A. Thromboembolic compli- cations of cancer: epidemiology, pathogenesis, diagnosis, and treat- ment[J]. Am J Hematol,2003,72(1) :43-52.
  • 7Ahiay G, Ciftei A, Demir M, et al. High plasma D-dimer level is associated with decreased survival in patients with lung cancer [ J ]. Clin Oncol (R Coil Radiol), 2007,19 (7) : 494-498.
  • 8Khorana A A, Streiff M B, Farge D, et al. Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action [ J ]. J Clin Oncol, 2009,27 (29) : 4919-4926.

二级参考文献18

共引文献97

同被引文献22

  • 1张天泽.肿瘤学[M].天津:天津科学技术出版社,2005.2669.
  • 2BIGGERSTAFF JP, SETH N, AMIRKHOSRAVI A, et al. Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo. and enhances experimental metastasis [ J ]. Clin Exp Metastasis. 1999,17 ( 8 ) :723-30.
  • 3Radhakrishna G, Berridge D. Cancer - related venous thromboembol- ic disease: current management and areas of uncertainty[ J]. Phlebol- ogy, 2012, 27(Suppl 2): 53-60.
  • 4Elyamany G, Alzahrani AM, Bukhary E. Cancer- associated throm- bosis: an overview[ J]. Clin Med Insights Onco,2014; 8:129 -137.
  • 5Abdullah WZ, Moufak SK, Yusof Z, et al. Shortened activated par- tial thromboplastin time, a hemostatic marker for hypercoagulable state during acute coronary event[J]. Transl Res,2010,155:315 -319.
  • 6Dres M, Ferrc A, Marie Allain Y, et al. Arterial and venous throm- bosis in lung cancer[ Jl. Rev Mal Respir. 2009,26(7) :783 -787.
  • 7Tas F, Kilic L, Serilmez M, et al. Clinical and prognostic signifi- cance of coagulation assays in lung cancer[ J]. Respir Med, 2013, 107 : 451 -457.
  • 8姜正华,朱慕云,桑慧颖,吕元文,丁平,卞京文.肺癌患者凝血常规指标检测的临床意义[J].临床肺科杂志,2009,14(6):725-726. 被引量:24
  • 9周辉,汪安兰,易青,徐建华.青年肺癌与老年肺癌的临床及病理表现对比分析[J].现代生物医学进展,2010,10(7):1308-1310. 被引量:12
  • 10宁亚,李文.组织因子途径抑制物-1与深静脉血栓形成的研究进展[J].中国老年学杂志,2010,30(11):1611-1613. 被引量:3

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部